SHZ · Financial Statements

Hualan Biological Vaccine Inc. (301207.SZ) Financial Statements

$17.77 SHZ: 301207.SZ Market Cap $10.64B

Full income statement, balance sheet, and cash flow statement for Hualan Biological Vaccine Inc. (301207.SZ), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio3.83
EV / EBITDA31.46
FCF Yield—
Quick Ratio3.66
Interest Coverage—
Return 1Y-4.77%
Return 3Y-30.55%
Return 5Y—

Hualan Biological Vaccine Inc. (301207.SZ) financials — frequently asked questions

What is 301207.SZ EV/EBITDA?

Hualan Biological Vaccine Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 31.46.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
301207.SZ Overview 301207.SZ Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.